MAKE PROTECTION
YOUR SUPERPOWER
International T2D, HF, and CKD guidelines recommend the use of an SGLT2i like SYNJARDY® as early as first line.1-6 such as:
References:
-
1.
Standards of care in diabetes 2023. Khan SE, od. Diabetes Care. 2023;46(suppl 1):S1-S291
-
2.
.Davies MJ, Aroda VR, Collins BS, et al. Management of hyperglycemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022:45(11):2753-2786.
-
3.
de Boer IH, Khunti K, Sadusky T, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022:45(12):3075-3090.
-
4.
Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Acad Cardiol. 2022/79/17):e263-6421.
-
5.
McDonagh TA, Matra M, Adamo M, et al: ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart fallure. Eur Heart J. 202):42(36):3599-3726.
-
6.
Rossing P, Caramori ML, Chan JCN, et al. Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022;102(5):990-999.
PC-AE-102257 | Expiry Date: 10/08/2026